PROZ Associated with Sorafenib Sensitivity May Serve as a Potential Target to Enhance the Efficacy of Combined Immunotherapy for Hepatocellular Carcinoma.
PROZ 与索拉非尼敏感性相关，可能成为增强肝细胞癌联合免疫疗法疗效的潜在靶点
期刊:Genes
影响因子:2.8
doi:10.3390/genes13091535
Chen Yinkui, Qiu Xiusheng, Wu Donghao, Lu Xu, Li Guanghui, Tang Yongsheng, Jia Changchang, Xiong Zhiyong, Wang Tiantian
